# US 2026/0248845 A1 · Compositions and methods for treating transient biofilms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0248845 A1
- Document ID: US20260248845A1
- Status: Published application
- Kind: A1
- Application number: 19/652,892
- Filed: 2026-04-20
- Published: 2026-08-27
- Earliest claimed: 2012-02-17
- Assignees: Wiab Water Innovation AB
- Applicants: Wiab Water Innovation AB
- Inventors: Geir Hermod Almås
- Web page: https://patentgrep.com/patent/US20260248845A1

## CPC

- A61K 33/20: Elemental chlorine; Inorganic compounds releasing chlorine
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0034: {Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- C01B 11/04: Hypochlorous acid
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C01B: NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; {METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C}

## Abstract

Disinfecting compositions containing hypochlorous acid and acetic acid are useful for treating transient biofilms in or on tissue without harming the natural flora of the tissue. The compositions are useful for treating a variety of types of tissue. Compositions are useful for treating and preventing orally-associated biofilm. Compositions may be provided in mouthwash form, spray form, gel form, cream form, dentifrice form, and may include nanoparticle encapsulated molecules for controlled release.

## Claims

### Claim 1

A composition comprising an organic acid and hypochlorous acid sufficient to treat pathogenic bacterial biofilm without harming natural biofilm of tissue.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the organic acid is acetic acid at a concentration is between about 0.1% and about 5.0%.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the hypochlorous acid concentration is between 10 ppm and 2500 ppm.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the hypochlorous acid concentration is approximately 150 ppm.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the acetic acid is present in a concentration sufficient to penetrate the tissue.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the tissue is skin tissue.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the skin tissue is epidermal tissue.

### Claim 8 (depends on 6)

The composition of claim 6, where in the tissue is vaginal tissue.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the composition is formulated in a spray, gel, cream, ointment, or oil.

### Claim 10 (depends on 2)

The composition of claim 2, wherein the acetic acid is encapsulated in a nanoparticle.

### Claim 11

A method for treating bacterial infection in tissue, the method comprising providing to the tissue a composition comprising acetic acid and an amount of hypochlorous acid effective to modulate a toxic property of the acetic acid without harming natural flora of the tissue.

### Claim 12 (depends on 11)

The method of claim 11, wherein the acetic acid is in a concentration sufficient to penetrate the tissue.

### Claim 13 (depends on 11)

The method of claim 11, wherein said acetic acid is present in an amount from about 0.1% to about 5.0% and said hypochlorous acid is present in a concentration from about 10 ppm to about 2500 ppm.

### Claim 14 (depends on 13)

The method of claim 13, wherein the tissue is skin tissue, and wherein the hypochlorous acid concentration is about 150 ppm, and wherein the acetic acid concentration is between about 0.1% and about 1.0%.

### Claim 15

A composition comprising acetic acid and hypochlorous acid sufficient to treat orally-associated bacterial biofilm.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the acetic acid concentration is between 0.1% and 1.0%.

### Claim 17 (depends on 15)

The composition of claim 15, wherein the hypochlorous acid concentration is between 5 ppm and 250 ppm.

### Claim 18 (depends on 15)

The composition of claim 15, wherein the composition does not harm natural biofilm.

### Claim 19 (depends on 15)

The composition of claim 15, wherein the acetic acid is present in a concentration sufficient to penetrate oral mucosa.

### Claim 20

A composition comprising acetic acid and hypochlourus acid sufficient to prevent orally-associated bacterial biofilm.

### Claim 21 (depends on 20)

The composition of claim 20, wherein the acetic acid concentration is between 0.1% and 1.0% and the hypochlorous acid is between 5 ppm and 250 ppm.

### Claim 22 (depends on 20)

The composition of claim 20, wherein the composition does not harm the natural flora.

### Claim 23

A method of treating orally-associated biofilm of an oral surface, the method comprising providing to the oral surface a composition comprising acetic acid and hypochlorous acid in an amount effective to treat to an oral surface suspected of being infected with orally-associated biofilm.

### Claim 24 (depends on 23)

The method of claim 23, wherein said acetic acid is present in an amount from about 0.1% to about 5.0% and said hypochlorous acid is present in a concentration from about 5 ppm to about 2500 ppm.

### Claim 25 (depends on 24)

The method of claim 24, wherein the oral surface comprises teeth and oral mucosa.

### Claim 26

A method of preventing orally-associated biofilm, the method comprising providing to an oral surface a composition comprising a prophylactically effective amount of acetic acid and hypochlorous acid.
